Asep Medical Holdings Inc (SEPSF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -2.71 Million | -3.61 Million | -1.19 Million | -22.12 Thousand | -47.95 Thousand |
| Net Income | -8.22 Million | -5.75 Million | -2.34 Million | -28.09 Thousand | -353.00 |
| Depreciation & Amortization | 1.29 Million | 1.28 Million | 177.17 Thousand | - | - |
| Deferred income taxes | - | -89.1 Thousand | 262.7 Thousand | - | - |
| Stock-based compensation | 1.95 Million | 1.11 Million | 956.22 Thousand | - | - |
| Change in working capital | 1.65 Million | -420.13 Thousand | -319.99 Thousand | -450.00 | -1267.00 |
| Other non-cash items | 4.49 Million | 250.58 Thousand | 76.38 Thousand | 6425.00 | -46.33 Thousand |
| Investing Cash Flow | -4471.00 | 124.79 Thousand | 146.08 Thousand | - | - |
| Investments in PPE | -4471.00 | -435.00 | -115.72 Thousand | - | - |
| Acquisitions | - | 125.23 Thousand | 261.8 Thousand | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -3244.00 | -435.00 | 211.49 Thousand | - | - |
| Financing Cash Flow | 651.4 Thousand | 330 Thousand | 6.33 Million | 30.05 Thousand | 47.54 Thousand |
| Debt repayment | -20 Thousand | -330 Thousand | -500 Thousand | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 631.4 Thousand | - | 140.5 Thousand | - | - |
| Other Financing Activities | -15.6 Thousand | 660 Thousand | 6.69 Million | 30.05 Thousand | 47.54 Thousand |
| Accounts receivables | 89.19 Thousand | -41.22 Thousand | -73.39 Thousand | - | - |
| Accounts payables | 570.56 Thousand | - | 124.87 Thousand | - | - |
| Inventory | - | - | 73.39 Thousand | - | - |
| Other working capital | 992.83 Thousand | -378.91 Thousand | -444.87 Thousand | -450.00 | -1267.00 |
| Cash at beginning of period | 2.13 Million | 5.29 Million | 8470.00 | 534.00 | 950.00 |
| Cash at end of period | 64.72 Thousand | 2.13 Million | 5.29 Million | 8470.00 | 534.00 |
| Capital Expenditure | -4471.00 | -435.00 | -115.72 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -2.06 Million | -3.15 Million | 5.28 Million | 7936.00 | -416.00 |
| Free Cash Flow | -2.71 Million | -3.61 Million | -1.3 Million | -22.12 Thousand | -47.95 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.12 Million | -762.02 Thousand | -8.22 Million | -2.01 Million | -2.1 Million | -2.8 Million |
| Depreciation & Amortization | 326.75 Thousand | 327.25 Thousand | 1.29 Million | 327.23 Thousand | 325.8 Thousand | 320.62 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 331.97 Thousand | 80.87 Thousand | 1.95 Million | 221.47 Thousand | 898.92 Thousand | 501.23 Thousand |
| Change in working capital | 584.61 Thousand | 398.67 Thousand | 1.65 Million | 510.58 Thousand | 117.63 Thousand | 593.95 Thousand |
| Other non-cash items | 230.5 Thousand | 152.85 Thousand | 4.49 Million | 1.03 Million | 98.31 Thousand | 713.22 Thousand |
| Investing Cash Flow | -190.00 | -190.00 | -4471.00 | -870.00 | -1369.00 | -1005.00 |
| Investments in PPE | -190.00 | -190.00 | -4471.00 | -870.00 | -1369.00 | -1005.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -190.00 | -190.00 | -3244.00 | -870.00 | -1369.00 | -1005.00 |
| Financing Cash Flow | 113.47 Thousand | 94.8 Thousand | 651.4 Thousand | 591.4 Thousand | 60 Thousand | - |
| Debt repayment | - | - | -20 Thousand | -20 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 631.4 Thousand | 571.4 Thousand | 60 Thousand | - |
| Other Financing Activities | 113.47 Thousand | 94.8 Thousand | -15.6 Thousand | 591.4 Thousand | 60 Thousand | - |
| Accounts receivables | -6188.00 | -8023.00 | 89.19 Thousand | 14.7 Thousand | -12.78 Thousand | -2512.00 |
| Accounts payables | 533.44 Thousand | 405.11 Thousand | 570.56 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 57.35 Thousand | 1588.00 | 992.83 Thousand | 46.13 Thousand | 130.41 Thousand | 596.46 Thousand |
| Cash at beginning of period | 18.66 Thousand | 64.72 Thousand | 2.13 Million | 263.11 Thousand | 872.63 Thousand | 1.55 Million |
| Cash at end of period | 25.3 Thousand | 18.66 Thousand | 64.72 Thousand | 64.72 Thousand | 263.11 Thousand | 872.63 Thousand |
| Capital Expenditure | -190.00 | -190.00 | -4471.00 | -870.00 | -1369.00 | -1005.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6637.00 | -46.05 Thousand | -2.06 Million | -198.39 Thousand | -609.52 Thousand | -678.1 Thousand |
| Free Cash Flow | -106.83 Thousand | -140.85 Thousand | -2.71 Million | -789.79 Thousand | -669.52 Thousand | -678.1 Thousand |
JMS
300827
600894
0T9J
300153
PLAN